#EPIGATE has taken the media and the allergy community by storm over the last week. Heather Bresch, CEO of Mylan, discussed the “broken system” on CNBC yesterday. We all know that the price of EpiPen is outrageous. But why? Is it all Mylan’s fault?

Continue reading